Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients

This publication has 54 references indexed in Scilit:

• Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant
  Clinical Transplantation, 2010
• Rapamycin promotes β-amyloid production via ADAM-10 inhibition
  Biochemical and Biophysical Research Communications, 2010
• T Cell‐mediated Rejection of Kidney Transplants: A Personal Viewpoint
  American Journal of Transplantation, 2010
• Scoring Total Inflammation Is Superior to the Current Banff Inflammation Score in Predicting Outcome and the Degree of Molecular Disturbance in Renal Allografts
  American Journal of Transplantation, 2009
• mTOR regulates memory CD8 T-cell differentiation
  Nature, 2009
• Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft Survival
  American Journal of Transplantation, 2007
• Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
  Blood, 2006
• Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection
  Transplant Immunology, 2005
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Frequent Expression of the Variant CD30 in Human Malignant Myeloid and Lymphoid Neoplasms
  The American Journal of Pathology, 1999